Early research (Phase 1)Study completedNCT03406949What this trial is testingMGD009/MGA012 Combination in Relapsed/Refractory CancerWho this might be right forAdvanced Solid Tumors MacroGenics 25
Testing effectiveness (Phase 2)UnknownNCT05320640What this trial is testingStudy of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid TumorsWho this might be right forRelapsed/Refractory Non-Hodgkin LymphomaAdvanced Solid Tumors Chinese PLA General Hospital 100
Early research (Phase 1)Looking for participantsNCT05892718What this trial is testingA Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological TumorsWho this might be right forAdvanced Solid TumorRefractory Non-Hodgkin Lymphoma FBD Biologics Limited 80
Not applicableNo Longer AvailableNCT05511350What this trial is testingExpanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001Who this might be right forSolid Tumor Metastatic Cancer Advanced Cancer I-Mab Biopharma US Limited
Early research (Phase 1)Study completedNCT05040932What this trial is testingStudy of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic MalignancyWho this might be right forCancer Eucure (Beijing) Biopharma Co., Ltd 8
Early research (Phase 1)Study completedNCT04836195What this trial is testingStudy of PCLX-001 in R/R Advanced Solid Malignancies and B-cell LymphomaWho this might be right forB-cell Non Hodgkin LymphomaAdvanced Solid Tumor Pacylex Pharmaceuticals 29
Early research (Phase 1)Ended earlyNCT05904236What this trial is testingSafety and Tolerability of Intravenous Administration of ICVB-1042Who this might be right forPatients With Advanced Solid Tumors IconOVir Bio 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05052255What this trial is testingRVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Ryvu Therapeutics SA 120
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT05631886What this trial is testingCombination of CAR-DC Vaccine and ICIs in Malignant TumorsWho this might be right forSolid Tumor, AdultLymphomaEphA2 Overexpression+4 more Chinese PLA General Hospital 10
Early research (Phase 1)Study completedNCT04659629What this trial is testingNL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory CancerWho this might be right forSolid TumorAdvanced Solid Tumor Neurogene Inc. 59
Early research (Phase 1)Study completedNCT03884556What this trial is testingTTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced CancersWho this might be right forSolid TumorLymphoma Trishula Therapeutics, Inc. 56
Early research (Phase 1)Study completedNCT02482441What this trial is testingA Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10Who this might be right forAdvanced Relapsed TumorsRefractory Solid Tumors OncoMed Pharmaceuticals, Inc. 50
Early research (Phase 1)Study completedNCT02225002What this trial is testingPhase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid TumorsWho this might be right forAdvanced Solid Tumors Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Ended earlyNCT03690154What this trial is testingEvaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AMLWho this might be right forAdvanced CancerSolid TumorsAcute Myeloid Leukemia Refractory+1 more Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 67
Early research (Phase 1)Study completedNCT01495663What this trial is testingDose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has ReturnedWho this might be right forCancer Cellectar Biosciences, Inc. 12
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT00741403What this trial is testingA Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced MalignanciesWho this might be right forAdvanced CancerMetastatic CancerLymphoma+2 more Cornerstone Pharmaceuticals 39